Pfizer Ireland Pharmaceuticals donates €60,000 to charity partner Marymount University Hospital & Hospice
Pfizer Ireland Pharmaceuticals has donated €60,000 to Marymount University Hospital & Hospice over the past three years. The donation was provided to support a number of capital projects that were identified as being required at the facility to enhance the existing infrastructure. The completed projects ensure the facility continues to meet its much-needed requirements into the future.
Members of Pfizer‘s senior management team recently visited Marymount‘s Curraheen facility to see how the company’s donation has benefited a number of projects. Speaking about why Marymount was chosen as Pfizer‘s charity partner, Seamus Fives, Vice President, Global APIO Operations at Pfizer, said “We are delighted to be able to support these projects to ensure the management and staff at Marymount have the facilities in place to continue to provide the excellent level of care to their patients. We support Marymount through both funding and voluntary assistance in terms of engineering and general maintenance, and we take great pride in giving back to such a worthy organisation which provides invaluable services for patients and their families.”
In 2016, a €25,000 donation from Pfizer Ireland Pharmaceuticals went towards replacing a hot water tank, relocating and replacing fire doors and modifying the Air Handling Unit intake to prevent water and rain damage. €35,000 provided in 2017 was used for access control at ward entrances and Community Palliative Care (CPC) offices, additional lighting protection, a CCTV hard drive upgrade, security room air conditioning, a health and safety gap analysis and a heritage project.
In addition to the financial support for Marymount, Pfizer Ireland Pharmaceutical’s GPTW (Great Place to Work) colleagues have organised many fundraising events and have raised thousands of euro for the Friends of Marymount. They have also participated in team building days at the Marymount facility where activities such as painting and gardening were carried out.
Commenting on the support received from Pfizer Ireland Pharmaceuticals to date, Sarah McCloskey, CEO at Marymount University Hospital & Hospice, said “We were delighted to welcome the Pfizer group to Marymount Hospice once again. We are incredibly appreciative of the great support from Pfizer over several years which has allowed us to fund key projects in our hight tech facility in Curraheen, Cork. Marymount provides essential specialist palliative care services and services for older people both on and off site. We need to raise €3 million every year through fundraising initiatives in order to provide our current and growing levels of service provision. Through Pfizer funding and volunteer support we have been able to achieve the completion of some key facilities projects which we would not have been able to advance otherwise.”
Pfizer is one of the world’s premier research-based biopharmaceutical companies. It is one of Ireland’s leading employers and the largest pharmaceutical sector investor and employer. One of the first pharmaceutical companies to locate in Ireland (1969), Pfizer has a rich heritage of innovation and expansion over a forty year period. Pfizer Ireland has over 3,300 colleagues across seven locations based in Cork, Dublin, Kildare and Sligo.